Etodolac (Lodine ®) in the treatment of osteoarthritis: Recent studies

Journal of Rheumatology

Volumn 24, Issue SUPPL. 47, 1997, Pages 23-31

  Schnitzer, Thomas J ^a,b   Constantine, Ginger ^a,c  

^a RUSH MEDICAL COLLEGE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

^c PFIZER INC   (United States)

Author keywords

Etodolac; Nabumetone; Naproxen; NSAID; Osteoarthritis; Safety

Indexed keywords

ETODOLAC; IODINE; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; ALKANONE;

ADULT; AGED; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DYSPEPSIA; FEMALE; FLATULENCE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; OSTEOARTHRITIS; PRIORITY JOURNAL; ARTICLE; COMPARATIVE STUDY; MIDDLE AGED; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BUTANONES; DOUBLE-BLIND METHOD; ETODOLAC; FEMALE; HUMANS; MALE; MIDDLE AGED; NAPROXEN; OSTEOARTHRITIS; PAIN MEASUREMENT; PLACEBOS;

EID: 0031050343     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Schuna AA, Vejraska BD: Rheumatoid arthritis and the seronegative spondyloarthropathies. In: DiPiro JT, Talbert RL, Hayes PE, Yee GC, Posey LM, eds. Pharmacotherapy. A Pathophysiologic Approach. New York: Elsevier Science Publishing Co. 1989:881-98.
2. Lipsky PE: Rheumatoid arthritis. In: Isselbacher KJ, Braaunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine, 13th ed. New York: McGraw-Hill, 1994:1648-55.
3. Howell DS: Osteoarthritis (degenerative joint disease). In: Wyngaarden JB, Smith LH Jr, eds. Cecil Textbook of Medicine, 18th ed. Philadelphia: WB Saunders, 1988:2039-41.
4. Pena M, Lizarazo H: Double-blind comparison of etodolac and naproxen in patients with osteoarthritis. Acta Ther 1991;17:5-18.
5. Brandt KD: Osteoarthritis. In: Isselbacher KJ, Braunwald, E, Wilson JD, Martin JB, Fauci AS, Kasper DL, eds. Harrison's Principles of Internal Medicine, 13th ed. New York: McGraw-Hill, 1994:1692-8.
6. ®) in France: An assessment of safety. Rheumatol Int 1990;(suppl)10:29-34.
7. ®) 300 mg b.i.d. in the treatment of osteoarthritis. Rheumatol Int 1993;13:S7-S12.
8. Eisenkolb T, Cawley MID, Dean S, Wagenhauser F: Double-blind, parallel-group evaluation of the safety and efficacy of etodolac compared with diclofenac in patients with osteoarthritis of the knee. Acta Ther 1993;19:137-50.
9. Grisanti AM, Lopes Vaz AA, Samara AM: Comparison of etodolac and diclofenac in osteoarthritis of the knee. Clin Ther 1992;14:791-800.
10. Platt PN: Recent clinical experience with etodolac in the treatment of osteoarthritis of the knee. Clin Rheumatol 1989;(suppl 1)8:54-62.
11. Chikanza IC, Clarke B, Hopkins R, MacFarlane DG, Bird H, Grahame R: A comparative study of the efficacy and toxicity of etodolac and naproxen in the treatment of osteoarthritis. Br J Clin Pract 1994;48:67-9.
12. Fioravanti A, Vaccai D, Megale F, Dragonetti C, Iudice A, Marcolongo R: Single-blind, randomized, parallel-group study of etodolac and naproxen in patients with osteoarthritis. Curr Ther Res 1989;46:648-53.
13. Palferman TG, Struthers GR, Williams PI: Double-blind, parallel comparison of etodolac and naproxen in patients with osteoarthritis of the knee. Acta Ther 1991;17:19-34.
14. Dick WC, Bulstra S, Schardijn GHC, Feenstra RM: Safety and efficacy of etodolac compared with piroxicam in patients with degenerative joint disease of the knee. Clin Ther 1992;14:517-26.
15. Freitas GG: A double-blind comparison of etodolac and piroxicam in the treatment of osteoarthritis. Curr Med Res Opin 1990;12:255-62.
16. Paulsen GA, Baigun S, de Figueiredo JG, de Freitas GG: Efficacy and tolerability comparison of etodolac and piroxicam in the treatment of patients with osteoarthritis of the knee. Curr Med Res Opin 1991;12:401-12.
17. Brasseur JP, Raeman F, Franchimont P: Double-blind parallel comparison of etodolac and diclofenac S.R. in patients with osteoarthritis of the knee. Acta Ther 1991;17:345-54.
18. Karbowski A: Double-blind, parallel comparison of etodolac and indomethacin in patients with osteoarthritis of the knee. Curr Med Res Opin 1991;12:309-17.
19. Dore R, Ballard I, Constantine G, McDonald P: Efficacy and safety of etodolac and naproxen in patients with osteoarthritis of the knee: A double-blind, placebo-controlled study. Clin Ther 1995;17:656-66.
20. Schnitzer TJ, Ballard IM, Constantine G, McDonald P: Double-blind, placebo-controlled comparison of the safety and efficacy of orally administered etodolac and nabumetone in patients with osteoarthritis of the knee. Clin Ther 1995;17:602-12.
21. Flynn BL: Rheumatoid arthritis and osteoarthritis: Current and future therapies. Am Pharm 1994;NS34:31-42.